News / Korea / yonhap_finance
COVID-19 Resurgence Triggers Rally in Korean Pharmaceutical and Diagnostic Stocks
Health Technology · Biotechnology · yonhap_finance · 2026-08-24
019170, 019175, 096530, 114450, 253840
Shares of Korean pharmaceutical and diagnostic companies surged as recent data showed a steady four-week increase in COVID-19 hospitalizations.
What Happened
Market Reaction: Shares of pharmaceutical and diagnostic companies in Korea saw significant gains following reports of a recent uptick in COVID-19 infections. Shin풍 Pharmaceutical and its preferred shares hit the daily upper limit, while companies like Sugentech and Seegene also experienced notable price increases.
Infection Trends: According to the Korea Disease Control and Prevention Agency, the number of hospitalized COVID-19 patients has risen for four consecutive weeks, reaching 56 in the 33rd week of the year. This steady climb from 23 cases in the 30th week has drawn renewed attention to the pandemic's status.
Official Stance: Health authorities noted that while hospitalization rates and virus detection levels are rising, they remain lower than those observed last year. Officials emphasized that the current situation does not pose a significant threat to the national public health system at this time.
Investment Caution: Investors are advised to exercise caution as these stocks are highly sensitive to news-driven volatility. Given that the price movements are largely sentiment-based rather than driven by fundamental earnings growth, market participants should monitor the situation closely.